Systemic JIA

High neutrophil counts decreased after initiation of recombinant interleukin-1 receptor agonist therapy in systemic-onset juvenile idiopathic arthritis.

IL-1 and IL-6 Inhibition Preferred in Systemic JIA

Since 2000, the German Biologics register (BiKeR) has prospectively enrolled children with juvenile idiopathic arthritis to assess outcomes with biologic…

Tocilizumab, IL-1 inhibitors yield 'significant response' for systemic juvenile idiopathic arthritis

A large segment of patients with systemic onset juvenile idiopathic arthritis experienced a significant…

IL-6 Inhibition Most Effective in Polycyclic Systemic JIA

The German Autoinflammatory Disease (AID)…

No Comments Yet.

Leave a comment